List of Publications
TSE Advisory Committee Meeting, February 20, 2003
L., et al. Factor VIII and
transmissible spongiform encephalopathy: the case for safety. Haemophilia 8:67-85, 2002. Review article.
N., et al. Brain and buffy coat
transmission of bovine spongiform encephalopathy to the primate Microcebus
murinus. Transfusion 42:
513-16, 2002. Single case of
transmission by buffy coat given i.c. to lemur.
N., et al. Transmission of prion
diseases by blood transfusion. J.
Gen. Virol. 83:2897-2905, 2002.
Sheep transfusion studies, using BSE and scrapie.
for Industry “Revised preventive measures to reduce the possible risk of
transmission of CJD and vCJD by blood and blood products.” Current guidance for blood donor
deferrals, published 1/2002. (http://www.fda.gov/cber/guidelines.htm)
K., et al. Solvent-dependent
precipitation of prion protein.
Biochimica et Biophysica Acta 1597: 28-35, 2002. Variations in pH, ionic strength, and
ethanol concentration conditions influence partitioning of PrpSc.
C., et al. Partitioning of human and sheep forms of the pathogenic
prion protein during the purification of therapeutic proteins from human
plasma. Transfusion 42: 1497-1500,
2002. Partitioning of pathogenic
prion protein in scaled-down plasma fractionation processes (Western blot
P., et al. Studies on the removal
of abnormal prion protein by processes used in the manufacture of human
plasma products. Vox Sang. 78:
86-95, 2000. Partitioning of
pathogenic prion protein in scaled-down plasma fractionation processes
(Western blot assay).
H.E. et al. Studies on the
removal of a bovine spongiform encephalopathy-derived agent by processes
used in the manufacture of human immunoglobulin. Vox Sang. 83:137-145, 2002.
Partitioning of BSE infectivity in scaled-down plasma fractionation
step, studied individually, and in series (bioassay).
J.D.F. et al. Tissue distribution
of protease resistant prion protein in variant CJD using a highly sensitive
immunoblotting assay. Lancet 358:
171-80, 2001. Western blot assay
for protease resistant prion protein in a single sample from a terminal
vCJD patient (fig. 5).
M.E. et al. Detection of variant
CJD infectivity in extraneural tissues.
Lancet 358: 208,9, 2001.
Bioassay of buffy coat and plasma from two patients with vCJD, for